| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Caffeine editorial
|
Schmidt, Barbara
|
|
|
25 |
6 |
p.
|
artikel
|
| 2 |
Caffeine exposure during pregnancy: Is it safe?
|
Baptiste-Roberts, Kesha
|
|
|
25 |
6 |
p.
|
artikel
|
| 3 |
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
|
Saroha, Vivek
|
|
|
25 |
6 |
p.
|
artikel
|
| 4 |
Childhood respiratory outcomes after neonatal caffeine therapy
|
Cheong, Jeanie L.Y.
|
|
|
25 |
6 |
p.
|
artikel
|
| 5 |
Cost-effectiveness and pricing of caffeine
|
Zupancic, John A.F.
|
|
|
25 |
6 |
p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
25 |
6 |
p.
|
artikel
|
| 7 |
History of caffeine use in neonatal medicine and the role of the CAP trial
|
Muehlbacher, Tobias
|
|
|
25 |
6 |
p.
|
artikel
|
| 8 |
Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa
|
Ekhaguere, Osayame A.
|
|
|
25 |
6 |
p.
|
artikel
|
| 9 |
National and international guidelines for neonatal caffeine use: Are they evidenced-based?
|
Eichenwald, Eric C.
|
|
|
25 |
6 |
p.
|
artikel
|
| 10 |
Neurodevelopmental outcomes after neonatal caffeine therapy
|
Synnes, Anne
|
|
|
25 |
6 |
p.
|
artikel
|
| 11 |
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns
|
Aranda, Jacob V.
|
|
|
25 |
6 |
p.
|
artikel
|
| 12 |
What is bronchopulmonary dysplasia and does caffeine prevent it?
|
Jensen, Erik A.
|
|
|
25 |
6 |
p.
|
artikel
|
| 13 |
When to start and stop caffeine and why respiratory status matters
|
Davis, Peter G.
|
|
|
25 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving